Nektar Therapeutics Dividends
The next dividend date for Nektar Therapeutics has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Nektar Therapeutics (NKTR)
More About Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Owning Nektar Therapeutics Stock on the Dividend Date
If you own Nektar Therapeutics stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Nektar Therapeutics stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Nektar Therapeutics stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Nektar Therapeutics stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Nektar Therapeutics dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Nektar Therapeutics Dividends
You can contact us any time if you would like to ask questions about Nektar Therapeutics dividends or anything else related to the stock market.